Insiders · Profile

Ottmer Matthew P.

Chief Operating Officer at Voyager Therapeutics. Filing since 21 Jan 2020. CIK 0001659870

Company

Date

Role

Action

Amount

Of holding

21 Jan 2020

Chief Operating Officer

Sold, plan not stated

3,724

$49.75K

12.4%

1 decision on file.